These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 17083064

  • 1. Effects of ACE inhibition and angiotensin II receptor blockade on glomerular basement membrane protein excretion and charge selectivity in type 2 diabetic patients.
    Deyneli O, Yavuz D, Velioglu A, Cacina H, Aksoy N, Haklar G, Taga Y, Akalin S.
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):98-103. PubMed ID: 17083064
    [Abstract] [Full Text] [Related]

  • 2. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 3. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
    Yavuz D, Koç M, Toprak A, Akpinar I, Velioğlu A, Deyneli O, Haklar G, Akalin S.
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H, Kanno Y, Kaneko K, Kaneko M, Kotaki S, Mimura T, Takane H.
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [Abstract] [Full Text] [Related]

  • 5. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
    Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M.
    Cas Lek Cesk; 1999 Oct 20; 138(18):560-4. PubMed ID: 10596472
    [Abstract] [Full Text] [Related]

  • 6. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T.
    Hypertens Res; 2008 Jan 20; 31(1):59-67. PubMed ID: 18360019
    [Abstract] [Full Text] [Related]

  • 7. Losartan ameliorates progression of glomerular structural changes in diabetic KKAy mice.
    Sasaki M, Uehara S, Ohta H, Taguchi K, Kemi M, Nishikibe M, Matsumoto H.
    Life Sci; 2004 Jul 02; 75(7):869-80. PubMed ID: 15183078
    [Abstract] [Full Text] [Related]

  • 8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 02; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II inhibition attenuates postexercise proteinuria in rats.
    Gündüz F, Kuru O, Sentürk UK.
    Int J Sports Med; 2005 Nov 02; 26(9):710-3. PubMed ID: 16237614
    [Abstract] [Full Text] [Related]

  • 10. Effect of combination therapy with a calcium channel blocker and an angiotensin-converting enzyme inhibitor on renal hypertrophy and urinary albumin excretion in diabetic rats.
    Nielsen B, Grønbaek H, Osterby R, Flyvbjerg A.
    Exp Diabesity Res; 2003 Nov 02; 4(3):191-9. PubMed ID: 15061647
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA, Rattan S.
    J Pharmacol Exp Ther; 2006 Aug 02; 318(2):725-34. PubMed ID: 16648368
    [Abstract] [Full Text] [Related]

  • 12. Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study.
    Pascual JM, Rodilla E, Miralles A, Gonzalez C, Redon J.
    J Hypertens; 2006 Nov 02; 24(11):2277-84. PubMed ID: 17053551
    [Abstract] [Full Text] [Related]

  • 13. Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy.
    Sato A, Tabata M, Hayashi K, Saruta T.
    Clin Exp Nephrol; 2003 Sep 02; 7(3):215-20. PubMed ID: 14586718
    [Abstract] [Full Text] [Related]

  • 14. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA, da Silva CG, Costa RS, Coimbra TM.
    Diabetes Metab Res Rev; 2003 Sep 02; 19(1):43-51. PubMed ID: 12592643
    [Abstract] [Full Text] [Related]

  • 15. Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome.
    Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M.
    Med Sci Monit; 2002 Feb 02; 8(2):BR69-74. PubMed ID: 11859270
    [Abstract] [Full Text] [Related]

  • 16. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L, Renke M, Rutkowski P, Rutkowski B, Lysiak-Szydłowska W.
    Med Sci Monit; 2005 Apr 02; 11(4):PI31-7. PubMed ID: 15795705
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec 02; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 18. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A, Bashir K, Anwar E.
    Nepal Med Coll J; 2007 Jun 02; 9(2):79-83. PubMed ID: 17899953
    [Abstract] [Full Text] [Related]

  • 19. Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition.
    Juhlin T, Erhardt LR, Ottosson H, Jönsson BA, Höglund P.
    Eur J Heart Fail; 2007 Feb 02; 9(2):191-6. PubMed ID: 16859993
    [Abstract] [Full Text] [Related]

  • 20. Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
    Lebovitz HE, Wiegmann TB, Cnaan A, Shahinfar S, Sica DA, Broadstone V, Schwartz SL, Mengel MC, Segal R, Versaggi JA.
    Kidney Int Suppl; 1994 Feb 02; 45():S150-5. PubMed ID: 8158885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.